Common variation in genes related to immune response and risk of childhood leukemia

Human Immunology

Volumn 73, Issue 3, 2012, Pages 316-319

  Han, Sohee ^a   Koo, Hong Hoe ^b   Lan, Qing ^c   Lee, Kyoung Mu ^d   Park, Ae Kyung ^e   Park, Sue K ^a,f   Sung, Hyuna ^f   Ahn, Hyo Seop ^a,f   Shin, Hee Young ^a,f   Kang, Hyoung Jin ^a,f   Seo, Jong Jin ^g   Ahn, Yoon Ok ^a   Kim, Ho ^h   Rothman, Nathaniel ^c   Kang, Daehee ^a,f,i  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Korea National Open University   (South Korea)

^e Sunchon National University   (South Korea)

^f Seoul National University   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h Seoul National University Hospital   (South Korea)

ⁱ Seoul National University   (South Korea)

Author keywords

Childhood leukemia; Immune response; Single nucleotide polymorphism

Indexed keywords

DEATH RECEPTOR; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TETRAHYDROFOLATE RECEPTOR SUPERFAMILY; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENETICS; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH2 CELL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNITY; INFANT; INFANT, NEWBORN; KOREA; LEUKEMIA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TRPM CATION CHANNELS;

EID: 84862781392     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.018     Document Type: Article

References (28)

1. Guise J.M., Austin D., Morris C.D. Review of case-control studies related to breastfeeding and reduced risk of childhood leukemia. Pediatrics 2005, 116:e724-e731.
2. Annual Report of the Central Cancer Registry in Korea: Central Cancer Registry Center in Korea, Ministry of Health and Welfare 2009, 12. Central Cancer Registry Center NCC, Ministry of Health and Welfare.
3. Roman E., Beral V. Possible aetiological factors in childhood leukaemia. Arch Dis Child 1991, 66:179-180.
4. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006, 6:193-203.
5. Duramad P., Tager I.B., Holland N.T. Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol Lett 2007, 172:48-59.
6. Zhang X.L., Komada Y., Chipeta J., Li Q.S., Inaba H., Azuma E., et al. Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia. Cancer Immunol Immunother 2000, 49:165-172.
7. Kinlen L.J. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer 1995, 71:1-5.
8. Louw L., Walsh C. HPV-induced recurrent laryngeal papillomatosis: dietary fatty acid and micronutrient intakes. Asia Pac J Clin Nutr 2008, 17:352-357.
9. Baldwin A.S. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001, 107:3-6.
10. Lee K.M., Ward M.H., Han S., Ahn H.S., Kang H.J., Choi H.S., et al. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res 2009, 33:250-258.
11. Lee K.M., Baris D., Zhang Y., Hosgood H.D., Menashe I., Yeager M., et al. Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut. Am J Hematol 2010, 85:560-563.
12. Han S., Lan Q., Park A.K., Lee K.M., Park S.K., Ahn H.S., et al. Polymorphisms in innate immunity genes and risk of childhood leukemia. Hum Immunol 2010, 71:727-730.
13. Shen M., Vermeulen R., Rajaraman P., Menashe I., He X., Chapman R.S., et al. Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. Environ Mol Mutagen 2009, 50:285-290.
14. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol 1995, 57:289-300.
15. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
16. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004, 32(suppl_1):D258-D261. Gene Ontology Consortium.
17. Katoh M., Katoh M. FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the eight-transmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products. Int J Oncol 2003, 22:1375-1381.
18. Tourneur L., Delluc S., Lévy V., Valensi F., Radford-Weiss I., Legrand O., et al. Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome. Cancer Res 2004, 64:8101-8108.
19. Rieux-Laucat F., Le Deist F., Hivroz C., Roberts I.A., Debatin K.M., Fischer A., et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995, 268:1347-1349.
20. Tourneur L., Buzyn A., Chiocchia G. FADD adaptor in cancer. Med Immunol 2005, 4:1.
21. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770-776.
22. Weng A.P., Aster J.C. Multiple niches for Notch in cancer: context is everything. Curr Opin Genet Dev 2004, 14:48-54.
23. Aster J.C., Pear W.S., Blacklow S.C. Notch signaling in leukemia. Annu Rev Pathol Mech Dis 2008, 3:587-613.
24. Liu D., Zhang Z., Liman E.R. Extracellular acid block and acid-enhanced inactivation of the Ca2+-activated cation channel TRPM5 involve residues in the S3-S4 and S5-S6 extracellular domains. J Biol Chem 2005, 280:20691-20699.
25. Monni O., Knuutila S. 11q deletions in hematological malignancies. Leuk Lymphoma 2001, 40:259-266.
26. Stronach E.A., Sellar G.C., Blenkiron C., Rabiasz G.J., Taylor K.J., Miller E.P., et al. Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. Cancer Res 2003, 63:8648-8655.
27. Tomlinson I.P., Strickland J.E., Lee A.S., Bromley L., Evans M.F., Morton J., et al. Loss of heterozygosity on chromosome 11 q in breast cancer. J Clin Pathol 1995, 48:424-428.
28. Takeuchi S., Cho S.K., Seriu T., Koike M., Bartram C.R., Reiter A., et al. Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia. Oncogene 1999, 18:7387-7388.